Brief: Pherecydes Pharma End-June Cash Position Of EUR 7.7 Mln

Pherecydes Pharma SA

13/10/2021 06:14

Oct 13 (Reuters) - Pherecydes Pharma SA  ALPHE.PA :
    * H1 OPERATING LOSS NARROWED 10 PERCENT TO -1.929 MILLION
EUR
    * H1 NET LOSS -1.454 MILLION EUR
    * OVER COMING MONTHS, COMPANY INTENDS TO CONTINUE
DEVELOPMENT OF
ITS VARIOUS ASSETS AND ACCELERATE RAMPING UP OF PRECISION PHAGE
THERAPY
    * OPERATING LOSS WAS EUR 1,929 THOUSAND IN FIRST HALF OF
2021
VERSUS EUR 2,146 THOUSAND IN FIRST HALF OF 2020
    * SHAREHOLDERS' EQUITY WAS EUR 10,942 THOUSAND AT JUNE 30,
2021
VERSUS EUR 5,285 THOUSAND AT DECEMBER 31, 2020
    * H1 OPERATING INCOME EUR 1.3 MILLION VERSUS EUR 0.4 MILLION
YEAR
AGO
    * AT JUNE 30, 2021, COMPANY HAD A CASH POSITION OF EUR 7,675
THOUSAND (VERSUS EUR 1,652 THOUSAND AT DECEMBER 31, 2020)

Source text for Eikon:  ID:nBw2DJxcCa 
Further company coverage:  ALPHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))